Indications
NeuroBloc is indicated for the treatment of cervical dystonia (torticollis). See section 5.1 for data on efficacy in patients responsive / resistant to botulinum toxin type A.
Composition
- Active substance
- botulinum toxin type B
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- NeuroBloc
- Active substance
- botulinum toxin type B
- ATC code
- M03AX01
- Therapeutic area
- Torticollis
- Marketing authorisation holder
- Sloan Pharma S.a.r.l
- Status
- Withdrawn
- EU authorisation
- 22 Jan 2001